Showing results (2131-2140 of 2,315) with videos related to

Sort By:
Pageof 232
International Journal of Molecular Sciences|December 11, 2022
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWHEeva Tortellini, Maria Antonella Zingaropoli, Giulia Mancarella, et al.
European Heart Journal|May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
Tumori|October 13, 2011
Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.
Animals : an Open Access Journal From MDPI|July 29, 2025
Impact of Dietary Enrichment with Omega-3 Polyunsaturated Fatty Acids from Extruded Linseed and Padina pavonica Algae Extract on Growth Performance and Metabolic Status in Fattening RabbitsAlda Quattrone, Doriana Beqiraj, Nour Elhouda Fehri, et al.
Diabetes Research and Clinical Practice|June 5, 2023
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registryPasquale Paolisso, Luca Bergamaschi, Arturo Cesaro, et al.
European Heart Journal|January 1, 2019
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient dataFrederik M Zimmermann, Elmir Omerovic, Stephane Fournier, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|July 9, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women: This statement was endorsed by the Heart Failure Society of America (HFSA)Suzanne J Baron, Josephine C Chou, Tayyab Shah, et al.
Cell Reports|November 9, 2022
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanomaPietro Carotenuto, Alessia Romano, Anna Barbato, et al.
Frontiers in Oncology|December 2, 2022
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experienceRossella Iula, Danilo De Novellis, Fabio Trastulli, et al.
Tumori|April 4, 2013
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.
Pageof 232